10-May-2024
No headlines found.
HCA Healthcare, Inc. to Present at June Healthcare Conference
Business Wire (Fri, 10-May 4:31 PM ET)
AREX Capital Expresses Disappointment in Enhabit's Strategic Review Conclusion
Globe Newswire (Thu, 9-May 9:15 AM ET)
MATTERWORKS ANNOUNCES UPDATES TO LEADERSHIP TEAM
PRNewswire (Thu, 2-May 10:02 AM ET)
HCA Healthcare Reports First Quarter 2024 Results
Business Wire (Fri, 26-Apr 7:30 AM ET)
Globe Newswire (Wed, 24-Apr 7:00 AM ET)
Business Wire (Tue, 23-Apr 9:30 AM ET)
Fortune Names HCA Healthcare One of the World's Most Admired Companies
Business Wire (Mon, 22-Apr 8:30 AM ET)
Business Wire (Fri, 19-Apr 9:30 AM ET)
HCA Healthcare, Inc. to Present at May Healthcare Conferences
Business Wire (Wed, 3-Apr 8:30 AM ET)
HCA Healthcare Releases 2024 Annual Impact Report
Business Wire (Thu, 28-Mar 8:30 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of May 10, 2024, HCA stock price climbed to $326.65 with 1,004,410 million shares trading.
HCA has a beta of 1.05, meaning it tends to be more sensitive to market movements. HCA has a correlation of 0.29 to the broad based SPY ETF.
HCA has a market cap of $85.55 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $17 billion in Revenue and $5.36 earnings per share. This beat revenue expectation by $559 million and exceeded earnings estimates by $.35.
In the last 3 years, HCA stock traded as high as $335.83 and as low as $164.47.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HCA stock has underperformed the market in the last year with a return of +18.2%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HCA shares. However, HCA has outperformed the market in the last 3 month and 2 week periods, returning +6.9% and +6.5%, while SPY returned +4.2% and +2.5%, respectively. This indicates HCA has been having a stronger performance recently.
HCA support price is $315.68 and resistance is $328.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA stock will trade within this expected range on the day.